ImaginAb inks pact with three global pharma companies

Clinical Research |  News | 0 Comment | 15 Oct, 2019

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party collaboration agreement with AstraZeneca, Pfizer Inc. and Takeda Pharmace...Read more

Thermo Fisher expands clinical trials capabilities in China

Clinical Research |  News | 0 Comment | 26 Sep, 2019

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials supply and distribution services network, in Suzhou, China. To ...Read more

WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

Clinical Research |  News | 0 Comment | 20 Sep, 2019

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now ope...Read more

Japan's Solasia set to start trials for Darinaparsin

Clinical Research |  News | 0 Comment | 20 Sep, 2019

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the target number of cases. The Phase 2 study was a multinational, single-gr...Read more

ASLAN presents Ph2 study data for Varlitinib tested on BTC patients

Clinical Research |  News | 0 Comment | 19 Sep, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late-breaking top line data from a phase 2 study conducted in China testi...Read more

Covance unveils new R&D center in Shanghai

Clinical Research |  News | 0 Comment | 17 Sep, 2019

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that its Covance Drug Development business celebrated the opening of its new...Read more

Novotech highlights South Korea's plans on clinical trials advancements

Clinical Research |  News | 0 Comment | 16 Sep, 2019

Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of Clinical Trials aimed at further establishing the country as a leading...Read more

Strekin AG completes patient recruitment in RESTORE Ph3 of STR001

Clinical Research |  News | 0 Comment | 15 Sep, 2019

Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has successfully completed patient recruitment in the RESTORE study, an int...Read more

IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”

Clinical Research |  News | 0 Comment | 02 Sep, 2019

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines, has announced that the clinical trial results of IBI303, an anti-t...Read more

Ascletis receives IND approval for its NASH drug

Clinical Research |  News | 0 Comment | 28 Aug, 2019

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver d...Read more

Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

Clinical Research |  News | 0 Comment | 27 Aug, 2019

ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announced that a late-breaking abstract detailing results from a phase...Read more

First patient dosed for Phase I/II trial of avapritinib in advanced GIST

Clinical Research |  News | 0 Comment | 26 Aug, 2019

CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II bridging the study of avapritinib, which was discovered by CStone's pa...Read more

New trial to evaluate an investigational drug for Parkinson's disease

Clinical Research |  News | 0 Comment | 26 Aug, 2019

Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication in people diagnosed with Parkinson's disease who are experiencing symp...Read more

CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia

Clinical Research |  News | 0 Comment | 23 Aug, 2019

CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Human Research Ethics Committee in Australia for the Phase I c...Read more

Luye Pharma's anti-depression drug to start clinical trials in Japan

Clinical Research |  News | 0 Comment | 22 Aug, 2019

Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005) for the treatment of d...Read more

Janssen reports positive Ph3 results of long-acting injectable HIV treatment regimen

Clinical Research |  News | 0 Comment | 22 Aug, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two...Read more

AstraZeneca announces positive results for heart drug candidate

Clinical Research |  News | 0 Comment | 20 Aug, 2019

AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpo...Read more

CStone announces first patient dosed in China with BLU-667

Clinical Research |  News | 0 Comment | 13 Aug, 2019

CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company'...Read more